Exelixis Inc (EXEL)
36.70
-0.14
(-0.38%)
USD |
NASDAQ |
Mar 28, 16:00
36.68
-0.02
(-0.05%)
After-Hours: 20:00
Exelixis Total Liabilities (Quarterly): 703.49M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 1.700B |
| Biomarin Pharmaceutical Inc | 1.331B |
| Catalyst Pharmaceuticals Inc | 123.78M |
| Incyte Corp | 1.997B |
| Blueprint Medicines Corp | 881.15M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.948B |
| Shareholders Equity (Quarterly) | 2.244B |
| Current Ratio | 3.635 |